Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Dominari Holdings Inc. (DOMH : NSDQ)

• Company Description    Dominari Holdings Inc. primarily focused on the development of a diverse portfolio of small-molecule anticancer and antiviral therapeutics and related patent technology. The Company's fintech and financial services business will be operated through its subsidiary, Dominari Financial Inc. Dominari Holdings Inc., formerly known as AIkido Pharma Inc., is based in NEW YORK. Number of Employees: 29

• Price / Volume Information    Yesterday's Closing Price: $4.95 Daily Weekly Monthly 20 Day Moving Average: 301,023 shares Shares Outstanding: 16.01 (millions) Market Capitalization: $79.26 (millions) Beta: 0.56 52 Week High: $13.58 52 Week Low: $1.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 18.14% 18.34% 12 Week -22.29% -23.55% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 725 5TH AVENUE 23RD FLOOR - NEW YORK,NY 10022 USA ph: 212-393-4540 fax: 703-992-9348 brett@haydenir.com http://www.dominariholdings.com

• General Corporate Information    Officers Anthony Hayes - Chief Executive Officer and Chairman of the Board Kyle Wool - President and Director Christopher Devall - Chief Operating Officer Tim S. Ledwick - Director Gregory James Blattner - Director Peer Information Dominari Holdings Inc. (GSAC) Dominari Holdings Inc. (CASI) Dominari Holdings Inc. (ALCD.) Dominari Holdings Inc. (OMNN) Dominari Holdings Inc. (CGPI.) Dominari Holdings Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 008875304 SIC: 6211 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 04/21/26 Share - Related Items Shares Outstanding: 16.01 Most Recent Split Date: 6.00 (0.06:1) Beta: 0.56 Market Capitalization: $79.26 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 04/21/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.38 Price/Cash Flow: - Price / Sales: 0.80 EPS Growth vs. Year Ago Period: 75.56% vs. Previous Quarter: 89.22% Sales Growth vs. Year Ago Period: 1,157.01% vs. Previous Quarter: 49.06% ROE 12/31/25 - - 09/30/25 - -50.80 06/30/25 - -94.32 ROA 12/31/25 - - 09/30/25 - -44.80 06/30/25 - -78.21 Current Ratio 12/31/25 - - 09/30/25 - 27.54 06/30/25 - 3.65 Quick Ratio 12/31/25 - - 09/30/25 - 27.54 06/30/25 - 3.65 Operating Margin 12/31/25 - - 09/30/25 - -48.61 06/30/25 - -93.38 Net Margin 12/31/25 - - 09/30/25 - 110.86 06/30/25 - -36.01 Pre-Tax Margin 12/31/25 - - 09/30/25 - 112.78 06/30/25 - -34.03 Book Value 12/31/25 - - 09/30/25 - 13.15 06/30/25 - 6.05 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00

Powered by Zacks Investment Research ©